Try our Advanced Search for more refined results
ISIS Pharmaceuticals, Inc. v. Santaris Pharma A/S Corp. et al
Case Number:
3:11-cv-02214
Court:
Nature of Suit:
Judge:
Firms
-
February 27, 2014
Santaris Can't Skirt Infringement Claim In Isis Patent Row
A California federal judge on Thursday refused to let Santaris Pharma A/S Corp. off the hook in Isis Pharmaceuticals Inc.'s infringement suit accusing Santaris of leveraging Isis' patented drug discovery development platform to sign multimillion-dollar development deals, saying Santaris isn't protected by a safe harbor statute.
-
September 20, 2012
Santaris Can't Skirt Isis Suit Over Drug Development Deals
A California federal judge on Wednesday refused to let Santaris Pharma A/S Corp. off the hook in Isis Pharmaceuticals Inc.'s infringement suit accusing its competitor of leveraging Isis' patented gapmer antisense drug development platform to sign multimillion-dollar deals with industry giants.
-
September 23, 2011
Isis Calls Out Santaris Over Drug Development Deals
Drug developer Isis Pharmaceuticals Inc. slammed Santaris Pharma A/S Corp. with a patent infringement lawsuit Thursday, accusing its competitor of leveraging Isis' patented gapmer antisense drug development platform to sign multimillion-dollar deals with drug industry giants.